iNtRON Biotechnology Inc (048530) — Financial Flexibility Index

Latest as of September 2025: -0.21x

iNtRON Biotechnology Inc (048530) has a Financial Flexibility Index of -0.21x as of September 2025. Free cash flow of ₩-993.53 Million (operating CF ₩-993.53 Million minus capex ₩0.00) represents 0% of total liabilities (₩4.73 Billion). Check iNtRON Biotechnology Inc (048530) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Financial Flexibility Index

-0.21x
Free Cash Flow / Total Liabilities

Free Cash Flow

₩-993.53 Million
Operating CF − Capex

Total Liabilities

₩4.73 Billion
KRW

Capital Expenditures

₩0.00
KRW

iNtRON Biotechnology Inc Financial Flexibility Index (2012–2024)

Historical Financial Flexibility Index trend for iNtRON Biotechnology Inc across 11 annual periods. For the full cash flow conversion analysis, see iNtRON Biotechnology Inc cash flow conversion.

Annual Financial Flexibility Index for iNtRON Biotechnology Inc (2012–2024)

Year-by-year free cash flow to debt coverage for iNtRON Biotechnology Inc. Explore debt repayment capacity of iNtRON Biotechnology Inc to assess how comfortably operating cash covers total debt obligations.

Year Flexibility Index Free Cash Flow (KRW) Operating CF Total Liabilities YoY Change
2024 0.40x ₩1.05 Billion ₩-138.47 Million ₩2.60 Billion ▼ -94.0%
2023 6.74x ₩12.67 Billion ₩3.12 Billion ₩1.88 Billion ▲ +2755.7%
2022 0.24x ₩8.21 Billion ₩5.98 Billion ₩34.78 Billion ▼ -37.1%
2021 0.38x ₩19.52 Billion ₩16.47 Billion ₩52.02 Billion ▼ -52.5%
2020 0.79x ₩11.98 Billion ₩7.13 Billion ₩15.16 Billion ▲ +3815.8%
2019 -0.02x ₩-512.11 Million ₩-812.48 Million ₩24.07 Billion ▼ -107.0%
2018 0.30x ₩4.75 Billion ₩4.20 Billion ₩15.70 Billion ▲ +203.6%
2017 -0.29x ₩-4.49 Billion ₩-5.47 Billion ₩15.38 Billion ▼ -3918.3%
2016 0.01x ₩79.99 Million ₩-4.64 Billion ₩10.46 Billion ▼ -99.4%
2015 1.35x ₩8.00 Billion ₩1.70 Billion ₩5.93 Billion ▲ +6382.5%
2012 0.02x ₩160.60 Million ₩-331.01 Million ₩7.72 Billion —
Financial Flexibility Index = (Operating CF − Capex) / Total Liabilities = Free Cash Flow / Total Liabilities